Form D — Qualigen Therapeutics, Inc.
0001641172-25-023575 · filed 2025-08-13
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $4,500,000
- Total sold
- $4,500,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Qualigen Therapeutics, Inc.
- CIK
- 1460702
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 5857 OWENS AVENUE
CARLSBAD, CA 92008 - Phone
- (760) 452-8111
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Kevin Richardson II · DirectorCarlsbad, CA Find on LinkedIn ↗
-
Campbell Becher · Executive OfficerCarlsbad, CA Find on LinkedIn ↗
-
Braeden Lichti · DirectorCarlsbad, CA Find on LinkedIn ↗
-
Robert B. Lim · DirectorCarlsbad, CA Find on LinkedIn ↗
-
Cody Price · DirectorCarlsbad, CA Find on LinkedIn ↗
View original on SEC EDGAR.